25 XP   0   0   10

Bavarian Nordic A/S ADR
Buy, Hold or Sell?

Let's analyse Bavarian Nordic A/S ADR together

PenkeI guess you are interested in Bavarian Nordic A/S ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bavarian Nordic A/S ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bavarian Nordic A/S ADR

I send you an email if I find something interesting about Bavarian Nordic A/S ADR.

Quick analysis of Bavarian Nordic A/S ADR (30 sec.)










What can you expect buying and holding a share of Bavarian Nordic A/S ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$43.51
Expected worth in 1 year
$48.02
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$4.50
Return On Investment
52.1%

For what price can you sell your share?

Current Price per Share
$8.65
Expected price per share
$7.845 - $10.65
How sure are you?
50%

1. Valuation of Bavarian Nordic A/S ADR (5 min.)




Live pricePrice per Share (EOD)

$8.65

Intrinsic Value Per Share

$1.92 - $19.88

Total Value Per Share

$45.43 - $63.40

2. Growth of Bavarian Nordic A/S ADR (5 min.)




Is Bavarian Nordic A/S ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$10.1b$7.5b$2.3b23.8%

How much money is Bavarian Nordic A/S ADR making?

Current yearPrevious yearGrowGrow %
Making money$35.8m$10.9m$24.8m69.4%
Net Profit Margin6.3%-0.3%--

How much money comes from the company's main activities?

3. Financial Health of Bavarian Nordic A/S ADR (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#43 / 1004

Most Revenue
#44 / 1004

Most Profit
#47 / 1004

Most Efficient
#128 / 1004

What can you expect buying and holding a share of Bavarian Nordic A/S ADR? (5 min.)

Welcome investor! Bavarian Nordic A/S ADR's management wants to use your money to grow the business. In return you get a share of Bavarian Nordic A/S ADR.

What can you expect buying and holding a share of Bavarian Nordic A/S ADR?

First you should know what it really means to hold a share of Bavarian Nordic A/S ADR. And how you can make/lose money.

Speculation

The Price per Share of Bavarian Nordic A/S ADR is $8.6475. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bavarian Nordic A/S ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bavarian Nordic A/S ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $43.51. Based on the TTM, the Book Value Change Per Share is $1.13 per quarter. Based on the YOY, the Book Value Change Per Share is $2.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bavarian Nordic A/S ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-0.8%0.151.8%0.070.8%0.020.3%0.010.2%
Usd Book Value Change Per Share-0.71-8.2%1.1313.0%2.1324.7%1.7320.0%0.9811.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.71-8.2%1.1313.0%2.1324.7%1.7320.0%0.9811.4%
Usd Price Per Share7.43-8.26-10.11-9.59-8.68-
Price to Earnings Ratio-26.05--5.97-83.84-8.92--4.65-
Price-to-Total Gains Ratio-10.49--2.38-7.89--5.64-8.96-
Price to Book Ratio0.17-0.20-0.32-0.40-0.75-
Price-to-Total Gains Ratio-10.49--2.38-7.89--5.64-8.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.6475
Number of shares115
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.131.73
Usd Total Gains Per Share1.131.73
Gains per Quarter (115 shares)129.51198.86
Gains per Year (115 shares)518.05795.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105185080795785
2010361026015911580
3015541544023862375
4020722062031823170
5025902580039773965
6031083098047734760
7036263616055685555
8041444134063646350
9046624652071597145
10051815170079557940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%8.012.00.040.0%17.023.00.042.5%21.040.00.034.4%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%10.010.00.050.0%21.019.00.052.5%30.028.03.049.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.061.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%10.010.00.050.0%21.019.00.052.5%30.028.03.049.2%

Fundamentals of Bavarian Nordic A/S ADR

About Bavarian Nordic A/S ADR

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2. The company has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Canada, France, Germany, Spain, Australia, Switzerland, Sweden, Chile, Taiwan, the United Kingdom, Hong Kong, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Fundamental data was last updated by Penke on 2024-05-15 01:31:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Bavarian Nordic A/S ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bavarian Nordic A/S ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • A Net Profit Margin of -13.8% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bavarian Nordic A/S ADR:

  • The MRQ is -13.8%. The company is making a huge loss. -2
  • The TTM is 6.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM6.3%-20.1%
TTM6.3%YOY-0.3%+6.7%
TTM6.3%5Y-17.5%+23.9%
5Y-17.5%10Y-80.3%+62.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-176.9%+163.1%
TTM6.3%-211.5%+217.8%
YOY-0.3%-266.0%+265.7%
5Y-17.5%-401.1%+383.6%
10Y-80.3%-552.5%+472.2%
1.1.2. Return on Assets

Shows how efficient Bavarian Nordic A/S ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • -0.1% Return on Assets means that Bavarian Nordic A/S ADR generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bavarian Nordic A/S ADR:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM0.2%-0.4%
TTM0.2%YOY0.1%+0.2%
TTM0.2%5Y0.0%+0.3%
5Y0.0%10Y0.0%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-12.1%+12.0%
TTM0.2%-11.7%+11.9%
YOY0.1%-11.0%+11.1%
5Y0.0%-13.2%+13.2%
10Y0.0%-14.5%+14.5%
1.1.3. Return on Equity

Shows how efficient Bavarian Nordic A/S ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • -0.2% Return on Equity means Bavarian Nordic A/S ADR generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bavarian Nordic A/S ADR:

  • The MRQ is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM0.3%-0.5%
TTM0.3%YOY0.1%+0.2%
TTM0.3%5Y0.0%+0.4%
5Y0.0%10Y-0.1%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-15.4%+15.2%
TTM0.3%-15.0%+15.3%
YOY0.1%-13.7%+13.8%
5Y0.0%-17.8%+17.8%
10Y-0.1%-19.3%+19.2%

1.2. Operating Efficiency of Bavarian Nordic A/S ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bavarian Nordic A/S ADR is operating .

  • Measures how much profit Bavarian Nordic A/S ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • An Operating Margin of -11.1% means the company generated $-0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bavarian Nordic A/S ADR:

  • The MRQ is -11.1%. The company is operating very inefficient. -2
  • The TTM is 7.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM7.6%-18.7%
TTM7.6%YOY7.8%-0.2%
TTM7.6%5Y-8.7%+16.3%
5Y-8.7%10Y-76.7%+68.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-339.4%+328.3%
TTM7.6%-221.5%+229.1%
YOY7.8%-281.8%+289.6%
5Y-8.7%-408.0%+399.3%
10Y-76.7%-528.5%+451.8%
1.2.2. Operating Ratio

Measures how efficient Bavarian Nordic A/S ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are $1.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bavarian Nordic A/S ADR:

  • The MRQ is 1.155. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.936. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.155TTM0.936+0.219
TTM0.936YOY0.955-0.019
TTM0.9365Y1.117-0.181
5Y1.11710Y1.791-0.675
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1553.076-1.921
TTM0.9363.246-2.310
YOY0.9553.609-2.654
5Y1.1175.190-4.073
10Y1.7916.896-5.105

1.3. Liquidity of Bavarian Nordic A/S ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bavarian Nordic A/S ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.64 means the company has $1.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bavarian Nordic A/S ADR:

  • The MRQ is 1.641. The company is able to pay all its short-term debts. +1
  • The TTM is 1.658. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.641TTM1.658-0.017
TTM1.658YOY2.193-0.535
TTM1.6585Y2.673-1.014
5Y2.67310Y3.562-0.889
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6413.802-2.161
TTM1.6584.158-2.500
YOY2.1935.249-3.056
5Y2.6736.087-3.414
10Y3.5626.428-2.866
1.3.2. Quick Ratio

Measures if Bavarian Nordic A/S ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • A Quick Ratio of 1.51 means the company can pay off $1.51 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bavarian Nordic A/S ADR:

  • The MRQ is 1.507. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.302. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.507TTM1.302+0.206
TTM1.302YOY2.848-1.547
TTM1.3025Y3.814-2.512
5Y3.81410Y5.455-1.641
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5073.246-1.739
TTM1.3023.811-2.509
YOY2.8485.150-2.302
5Y3.8145.929-2.115
10Y5.4556.351-0.896

1.4. Solvency of Bavarian Nordic A/S ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bavarian Nordic A/S ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bavarian Nordic A/S ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Bavarian Nordic A/S ADR assets are financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bavarian Nordic A/S ADR:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.297. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.297-0.044
TTM0.297YOY0.398-0.101
TTM0.2975Y0.391-0.094
5Y0.39110Y0.343+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2530.351-0.098
TTM0.2970.343-0.046
YOY0.3980.278+0.120
5Y0.3910.366+0.025
10Y0.3430.379-0.036
1.4.2. Debt to Equity Ratio

Measures if Bavarian Nordic A/S ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.9% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bavarian Nordic A/S ADR:

  • The MRQ is 0.339. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.428. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.428-0.089
TTM0.428YOY0.673-0.246
TTM0.4285Y0.722-0.294
5Y0.72210Y0.578+0.144
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3390.402-0.063
TTM0.4280.415+0.013
YOY0.6730.351+0.322
5Y0.7220.442+0.280
10Y0.5780.469+0.109

2. Market Valuation of Bavarian Nordic A/S ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bavarian Nordic A/S ADR generates.

  • Above 15 is considered overpriced but always compare Bavarian Nordic A/S ADR to the Biotechnology industry mean.
  • A PE ratio of -26.05 means the investor is paying $-26.05 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bavarian Nordic A/S ADR:

  • The EOD is -30.315. Based on the earnings, the company is expensive. -2
  • The MRQ is -26.047. Based on the earnings, the company is expensive. -2
  • The TTM is -5.970. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-30.315MRQ-26.047-4.268
MRQ-26.047TTM-5.970-20.077
TTM-5.970YOY83.845-89.814
TTM-5.9705Y8.916-14.886
5Y8.91610Y-4.650+13.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-30.315-2.413-27.902
MRQ-26.047-2.573-23.474
TTM-5.970-2.766-3.204
YOY83.845-3.948+87.793
5Y8.916-6.374+15.290
10Y-4.650-6.660+2.010
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bavarian Nordic A/S ADR:

  • The EOD is 8.096. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.956. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 17.469. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.096MRQ6.956+1.140
MRQ6.956TTM17.469-10.513
TTM17.469YOY-26.730+44.199
TTM17.4695Y-11.099+28.568
5Y-11.09910Y-15.537+4.437
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.096-3.085+11.181
MRQ6.956-3.312+10.268
TTM17.469-3.529+20.998
YOY-26.730-5.200-21.530
5Y-11.099-8.251-2.848
10Y-15.537-8.842-6.695
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bavarian Nordic A/S ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.17 means the investor is paying $0.17 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bavarian Nordic A/S ADR:

  • The EOD is 0.199. Based on the equity, the company is cheap. +2
  • The MRQ is 0.171. Based on the equity, the company is cheap. +2
  • The TTM is 0.196. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.199MRQ0.171+0.028
MRQ0.171TTM0.196-0.025
TTM0.196YOY0.320-0.124
TTM0.1965Y0.400-0.204
5Y0.40010Y0.748-0.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1992.082-1.883
MRQ0.1712.031-1.860
TTM0.1962.076-1.880
YOY0.3202.688-2.368
5Y0.4003.692-3.292
10Y0.7484.104-3.356
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bavarian Nordic A/S ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.7081.126-163%2.134-133%1.729-141%0.983-172%
Book Value Per Share--43.51142.269+3%32.190+35%27.346+59%17.490+149%
Current Ratio--1.6411.658-1%2.193-25%2.673-39%3.562-54%
Debt To Asset Ratio--0.2530.297-15%0.398-36%0.391-35%0.343-26%
Debt To Equity Ratio--0.3390.428-21%0.673-50%0.722-53%0.578-41%
Dividend Per Share----0%-0%-0%-0%
Eps---0.0710.153-147%0.072-199%0.023-409%0.015-588%
Free Cash Flow Per Share--0.2670.160+67%-0.209+178%-0.154+158%-0.076+128%
Free Cash Flow To Equity Per Share--0.2600.182+43%-0.031+112%0.083+215%0.066+296%
Gross Profit Margin--1.7751.204+47%-0.160+109%0.765+132%0.831+114%
Intrinsic Value_10Y_max--19.884--------
Intrinsic Value_10Y_min--1.921--------
Intrinsic Value_1Y_max--0.028--------
Intrinsic Value_1Y_min---0.278--------
Intrinsic Value_3Y_max--1.582--------
Intrinsic Value_3Y_min---0.433--------
Intrinsic Value_5Y_max--4.940--------
Intrinsic Value_5Y_min---0.146--------
Market Cap2022062220.000+14%1737371760.0001930838511.000-10%2363170495.800-26%2241861961.680-23%2030692959.120-14%
Net Profit Margin---0.1380.063-317%-0.003-98%-0.175+27%-0.803+483%
Operating Margin---0.1110.076-246%0.078-242%-0.087-22%-0.767+592%
Operating Ratio--1.1550.936+23%0.955+21%1.117+3%1.791-36%
Pb Ratio0.199+14%0.1710.196-13%0.320-47%0.400-57%0.748-77%
Pe Ratio-30.315-16%-26.047-5.970-77%83.845-131%8.916-392%-4.650-82%
Price Per Share8.648+14%7.4308.257-10%10.106-26%9.587-23%8.684-14%
Price To Free Cash Flow Ratio8.096+14%6.95617.469-60%-26.730+484%-11.099+260%-15.537+323%
Price To Total Gains Ratio-12.206-16%-10.488-2.379-77%7.892-233%-5.637-46%8.957-217%
Quick Ratio--1.5071.302+16%2.848-47%3.814-60%5.455-72%
Return On Assets---0.0010.002-152%0.001-253%0.000-79%0.000-65%
Return On Equity---0.0020.003-147%0.001-253%0.000-70%-0.001-58%
Total Gains Per Share---0.7081.126-163%2.134-133%1.729-141%0.983-172%
Usd Book Value--10174272000.0009883954500.000+3%7526953250.000+35%6394394700.000+59%4089833550.000+149%
Usd Book Value Change Per Share---0.7081.126-163%2.134-133%1.729-141%0.983-172%
Usd Book Value Per Share--43.51142.269+3%32.190+35%27.346+59%17.490+149%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0710.153-147%0.072-199%0.023-409%0.015-588%
Usd Free Cash Flow--62439880.70037441621.750+67%-48834706.100+178%-36033307.405+158%-17792945.923+128%
Usd Free Cash Flow Per Share--0.2670.160+67%-0.209+178%-0.154+158%-0.076+128%
Usd Free Cash Flow To Equity Per Share--0.2600.182+43%-0.031+112%0.083+215%0.066+296%
Usd Market Cap2022062220.000+14%1737371760.0001930838511.000-10%2363170495.800-26%2241861961.680-23%2030692959.120-14%
Usd Price Per Share8.648+14%7.4308.257-10%10.106-26%9.587-23%8.684-14%
Usd Profit---16675510.70035855713.675-147%10961302.400-252%4217650.750-495%1506199.248-1207%
Usd Revenue--121145470.400242006060.875-50%148715625.750-19%111698814.205+8%73900926.815+64%
Usd Total Gains Per Share---0.7081.126-163%2.134-133%1.729-141%0.983-172%
 EOD+4 -4MRQTTM+16 -18YOY+14 -205Y+16 -1810Y+18 -16

3.2. Fundamental Score

Let's check the fundamental score of Bavarian Nordic A/S ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-30.315
Price to Book Ratio (EOD)Between0-10.199
Net Profit Margin (MRQ)Greater than0-0.138
Operating Margin (MRQ)Greater than0-0.111
Quick Ratio (MRQ)Greater than11.507
Current Ratio (MRQ)Greater than11.641
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.339
Return on Equity (MRQ)Greater than0.15-0.002
Return on Assets (MRQ)Greater than0.05-0.001
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Bavarian Nordic A/S ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5078.345
Ma 20Greater thanMa 507.543
Ma 50Greater thanMa 1007.554
Ma 100Greater thanMa 2007.758
OpenGreater thanClose8.630
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets13,620,931
Total Liabilities3,446,659
Total Stockholder Equity10,174,272
 As reported
Total Liabilities 3,446,659
Total Stockholder Equity+ 10,174,272
Total Assets = 13,620,931

Assets

Total Assets13,620,931
Total Current Assets4,816,735
Long-term Assets8,804,196
Total Current Assets
Cash And Cash Equivalents 860,814
Short-term Investments 1,431,085
Net Receivables 701,467
Inventory 1,782,887
Other Current Assets 40,482
Total Current Assets  (as reported)4,816,735
Total Current Assets  (calculated)4,816,735
+/-0
Long-term Assets
Property Plant Equipment 2,377,673
Intangible Assets 6,404,392
Long-term Assets Other 22,131
Long-term Assets  (as reported)8,804,196
Long-term Assets  (calculated)8,804,196
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,935,253
Long-term Liabilities511,406
Total Stockholder Equity10,174,272
Total Current Liabilities
Short-term Debt 46,927
Short Long Term Debt 1,913
Accounts payable 480,274
Other Current Liabilities 2,095,275
Total Current Liabilities  (as reported)2,935,253
Total Current Liabilities  (calculated)2,624,389
+/- 310,864
Long-term Liabilities
Long term Debt 14,664
Capital Lease Obligations 117,016
Long-term Liabilities Other 320,558
Long-term Liabilities  (as reported)511,406
Long-term Liabilities  (calculated)452,238
+/- 59,168
Total Stockholder Equity
Common Stock780,978
Retained Earnings 9,220,777
Accumulated Other Comprehensive Income 173,808
Other Stockholders Equity -1,291
Total Stockholder Equity (as reported)10,174,272
Total Stockholder Equity (calculated)10,174,272
+/-0
Other
Capital Stock780,978
Cash and Short Term Investments 2,291,899
Common Stock Shares Outstanding 228,902
Current Deferred Revenue312,777
Liabilities and Stockholders Equity 13,620,931
Net Debt -727,221
Net Invested Capital 10,190,849
Net Working Capital 1,881,482
Property Plant and Equipment Gross 2,377,673
Short Long Term Debt Total 133,593



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
1,271,104
1,442,300
1,560,500
1,370,600
1,467,128
1,377,100
1,940,200
1,842,600
1,976,587
1,885,900
1,689,300
1,644,000
1,539,181
1,389,200
1,497,600
1,454,400
1,452,206
1,332,400
1,255,200
1,263,800
1,887,268
2,463,900
2,220,600
2,139,139
1,989,263
1,862,610
2,481,714
2,582,921
2,823,698
2,881,566
3,068,199
2,916,240
3,152,671
3,029,816
3,155,562
3,103,313
3,060,936
2,761,815
2,672,034
2,563,218
7,047,068
9,005,271
9,242,710
9,451,135
8,759,064
9,748,434
10,008,378
10,117,524
12,089,269
11,991,549
12,028,556
12,295,000
12,391,246
13,180,857
14,993,241
13,399,238
14,353,213
13,620,931
13,620,93114,353,21313,399,23814,993,24113,180,85712,391,24612,295,00012,028,55611,991,54912,089,26910,117,52410,008,3789,748,4348,759,0649,451,1359,242,7109,005,2717,047,0682,563,2182,672,0342,761,8153,060,9363,103,3133,155,5623,029,8163,152,6712,916,2403,068,1992,881,5662,823,6982,582,9212,481,7141,862,6101,989,2632,139,1392,220,6002,463,9001,887,2681,263,8001,255,2001,332,4001,452,2061,454,4001,497,6001,389,2001,539,1811,644,0001,689,3001,885,9001,976,5871,842,6001,940,2001,377,1001,467,1281,370,6001,560,5001,442,3001,271,104000
   > Total Current Assets 
0
0
0
555,981
697,800
798,500
562,900
637,940
524,800
1,068,000
969,000
1,111,359
1,043,000
1,043,000
1,008,300
894,921
736,200
941,600
868,700
900,369
771,900
673,100
671,300
1,319,123
1,923,900
1,702,600
1,586,396
1,404,258
1,248,654
1,845,206
1,998,508
2,282,567
2,347,042
2,559,990
2,575,004
2,770,485
2,628,431
2,710,095
2,622,727
2,508,256
2,078,009
1,879,219
1,681,076
654,874
2,630,588
2,887,721
3,091,224
2,381,047
3,342,901
3,581,983
3,593,960
4,753,639
4,439,425
4,357,749
4,545,764
4,484,580
5,123,141
4,415,086
4,461,201
5,403,051
4,816,735
4,816,7355,403,0514,461,2014,415,0865,123,1414,484,5804,545,7644,357,7494,439,4254,753,6393,593,9603,581,9833,342,9012,381,0473,091,2242,887,7212,630,588654,8741,681,0761,879,2192,078,0092,508,2562,622,7272,710,0952,628,4312,770,4852,575,0042,559,9902,347,0422,282,5671,998,5081,845,2061,248,6541,404,2581,586,3961,702,6001,923,9001,319,123671,300673,100771,900900,369868,700941,600736,200894,9211,008,3001,043,0001,043,0001,111,359969,0001,068,000524,800637,940562,900798,500697,800555,981000
       Cash And Cash Equivalents 
0
0
0
80,954
203,700
102,800
198,000
266,783
121,900
172,100
50,600
272,107
253,600
232,000
266,400
353,545
139,500
294,000
148,800
346,799
227,200
114,600
146,000
398,357
1,019,300
505,200
462,345
374,063
185,008
459,220
209,333
853,596
1,005,168
358,134
459,188
282,521
150,347
179,551
345,652
266,658
140,312
114,172
104,555
297,545
1,464,523
376,921
561,445
285,487
245,835
185,901
341,822
591,820
401,366
290,801
718,646
575,407
1,271,717
831,802
1,032,182
1,477,234
860,814
860,8141,477,2341,032,182831,8021,271,717575,407718,646290,801401,366591,820341,822185,901245,835285,487561,445376,9211,464,523297,545104,555114,172140,312266,658345,652179,551150,347282,521459,188358,1341,005,168853,596209,333459,220185,008374,063462,345505,2001,019,300398,357146,000114,600227,200346,799148,800294,000139,500353,545266,400232,000253,600272,10750,600172,100121,900266,783198,000102,800203,70080,954000
       Short-term Investments 
0
0
0
104,045
138,900
96,000
97,100
88,871
91,200
507,900
461,100
311,919
275,300
279,300
280,000
196,359
283,500
280,600
282,500
185,282
187,700
188,900
90,100
581,350
588,200
781,100
780,544
692,722
793,189
1,048,721
1,054,077
1,061,248
1,051,226
1,954,443
1,956,980
2,311,912
2,295,699
2,300,308
2,063,042
2,050,556
1,787,542
1,523,558
1,391,041
174,819
740,627
2,002,986
2,007,662
1,384,120
2,342,787
2,327,547
2,296,242
3,124,795
3,045,703
2,962,638
2,522,932
2,269,759
1,699,447
553,097
474,064
390,247
1,431,085
1,431,085390,247474,064553,0971,699,4472,269,7592,522,9322,962,6383,045,7033,124,7952,296,2422,327,5472,342,7871,384,1202,007,6622,002,986740,627174,8191,391,0411,523,5581,787,5422,050,5562,063,0422,300,3082,295,6992,311,9121,956,9801,954,4431,051,2261,061,2481,054,0771,048,721793,189692,722780,544781,100588,200581,35090,100188,900187,700185,282282,500280,600283,500196,359280,000279,300275,300311,919461,100507,90091,20088,87197,10096,000138,900104,045000
       Net Receivables 
0
0
0
202,549
0
486,900
0
0
0
0
0
0
353,500
0
113,400
56,592
87,600
111,000
190,300
110,117
129,900
105,800
184,400
186,783
68,400
183,300
88,900
137,927
51,405
56,154
495,253
130,391
13,099
4,411
18,068
19,396
12,011
30,883
21,668
31,227
20,125
82,188
42,088
43,405
210,604
318,286
130,662
139,292
182,603
367,792
346,188
448,141
388,786
536,266
680,459
566,408
783,653
1,344,152
1,182,584
1,873,324
701,467
701,4671,873,3241,182,5841,344,152783,653566,408680,459536,266388,786448,141346,188367,792182,603139,292130,662318,286210,60443,40542,08882,18820,12531,22721,66830,88312,01119,39618,0684,41113,099130,391495,25356,15451,405137,92788,900183,30068,400186,783184,400105,800129,900110,117190,300111,00087,60056,592113,4000353,500000000486,9000202,549000
       Other Current Assets 
0
0
0
26,010
117,400
-90,900
145,700
160,834
164,600
173,200
182,100
308,408
-112,500
269,000
206,500
115,816
128,600
133,800
219,700
134,637
152,400
133,300
202,400
217,569
104,300
208,900
122,551
176,402
85,671
74,520
511,632
150,671
33,759
24,712
39,956
42,005
46,834
68,259
60,906
90,154
53,660
122,068
84,861
81,748
238,674
353,218
164,652
190,358
201,448
401,092
402,618
556,981
-1
585,901
712,972
720,342
165,238
177,632
32,423
18,510
40,482
40,48218,51032,423177,632165,238720,342712,972585,901-1556,981402,618401,092201,448190,358164,652353,218238,67481,74884,861122,06853,66090,15460,90668,25946,83442,00539,95624,71233,759150,671511,63274,52085,671176,402122,551208,900104,300217,569202,400133,300152,400134,637219,700133,800128,600115,816206,500269,000-112,500308,408182,100173,200164,600160,834145,700-90,900117,40026,010000
   > Long-term Assets 
0
0
0
715,123
744,500
762,000
807,700
829,188
852,300
872,200
873,600
865,228
842,900
646,300
635,700
644,260
653,000
556,000
585,700
551,837
560,500
582,100
592,500
568,145
540,000
518,000
552,743
585,005
613,956
636,508
584,413
541,131
534,524
508,209
341,236
382,186
401,385
445,467
480,586
552,680
683,806
792,815
882,142
6,392,194
6,374,683
6,354,989
6,359,911
6,378,017
6,405,533
6,426,395
6,523,564
7,335,630
7,552,124
7,670,807
7,749,236
7,906,666
8,057,716
10,578,155
8,938,037
8,950,162
8,804,196
8,804,1968,950,1628,938,03710,578,1558,057,7167,906,6667,749,2367,670,8077,552,1247,335,6306,523,5646,426,3956,405,5336,378,0176,359,9116,354,9896,374,6836,392,194882,142792,815683,806552,680480,586445,467401,385382,186341,236508,209534,524541,131584,413636,508613,956585,005552,743518,000540,000568,145592,500582,100560,500551,837585,700556,000653,000644,260635,700646,300842,900865,228873,600872,200852,300829,188807,700762,000744,500715,123000
       Property Plant Equipment 
0
0
0
354,485
348,300
347,800
355,800
360,815
362,600
360,100
461,500
348,780
342,100
332,600
328,600
320,534
313,900
310,900
316,700
322,746
325,900
331,200
333,700
336,573
327,200
323,100
318,697
325,760
322,039
326,837
322,512
326,336
319,251
314,673
309,916
347,978
369,628
414,021
448,979
518,808
652,563
763,508
854,558
906,494
946,659
977,745
991,709
1,083,143
1,166,417
1,231,841
1,341,961
1,488,511
1,619,063
1,687,612
1,714,614
1,751,406
1,745,591
2,423,629
2,381,439
2,452,685
2,377,673
2,377,6732,452,6852,381,4392,423,6291,745,5911,751,4061,714,6141,687,6121,619,0631,488,5111,341,9611,231,8411,166,4171,083,143991,709977,745946,659906,494854,558763,508652,563518,808448,979414,021369,628347,978309,916314,673319,251326,336322,512326,837322,039325,760318,697323,100327,200336,573333,700331,200325,900322,746316,700310,900313,900320,534328,600332,600342,100348,780461,500360,100362,600360,815355,800347,800348,300354,485000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,334
1,331
1,384
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,3841,3311,3340000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
126,800
129,100
131,600
131,600
133,585
132,000
131,800
17,800
131,926
129,100
133,300
135,200
148,485
157,000
65,400
94,800
104,629
112,700
115,300
120,100
109,194
90,400
94,700
96,867
108,189
120,756
131,698
103,098
83,019
71,796
49,900
29,862
32,992
30,422
30,100
30,259
32,500
29,909
27,976
26,200
5,484,255
5,424,399
5,373,285
5,364,074
5,290,752
5,234,554
5,189,871
5,162,139
5,803,956
5,880,752
5,813,476
5,864,519
5,942,637
6,083,663
7,904,276
6,535,348
6,481,736
6,404,392
6,404,3926,481,7366,535,3487,904,2766,083,6635,942,6375,864,5195,813,4765,880,7525,803,9565,162,1395,189,8715,234,5545,290,7525,364,0745,373,2855,424,3995,484,25526,20027,97629,90932,50030,25930,10030,42232,99229,86249,90071,79683,019103,098131,698120,756108,18996,86794,70090,400109,194120,100115,300112,700104,62994,80065,400157,000148,485135,200133,300129,100131,92617,800131,800132,000133,585131,600131,600129,100126,800000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,776
143,477
143,636
1,458
11
13
1,346
1,348
1,372
0
1,331
1,384
1,445
3,625
3,959
4,128
4,122
4,562
4,683
19,464
43,163
52,309
169,719
170,103
212,623
0
250,250
21,250
0
0
0021,250250,2500212,623170,103169,71952,30943,16319,4644,6834,5624,1224,1283,9593,6251,4451,3841,33101,3721,3481,34613111,458143,636143,477131,7760000000000000000000000000000000
> Total Liabilities 
0
0
0
566,890
542,700
738,200
675,300
656,693
650,600
664,000
646,200
768,987
690,900
669,600
591,700
539,505
427,700
531,500
457,800
475,916
353,700
330,200
382,300
635,174
1,195,000
871,800
836,476
646,784
650,177
677,233
668,325
806,461
841,796
945,594
278,852
646,374
696,763
905,731
824,772
880,308
674,663
685,457
671,116
5,181,613
3,894,718
3,991,561
4,187,018
3,864,711
3,827,691
4,219,828
4,346,825
4,714,602
4,866,251
5,149,461
5,337,170
5,241,259
4,059,956
5,307,490
4,063,375
4,013,281
3,446,659
3,446,6594,013,2814,063,3755,307,4904,059,9565,241,2595,337,1705,149,4614,866,2514,714,6024,346,8254,219,8283,827,6913,864,7114,187,0183,991,5613,894,7185,181,613671,116685,457674,663880,308824,772905,731696,763646,374278,852945,594841,796806,461668,325677,233650,177646,784836,476871,8001,195,000635,174382,300330,200353,700475,916457,800531,500427,700539,505591,700669,600690,900768,987646,200664,000650,600656,693675,300738,200542,700566,890000
   > Total Current Liabilities 
0
0
0
453,866
428,800
619,900
565,800
550,184
549,900
566,200
547,200
663,578
589,200
567,300
492,800
485,262
372,700
436,400
363,900
389,252
269,200
247,500
292,300
583,278
1,143,600
820,900
786,603
590,234
594,142
621,712
612,720
751,798
787,665
891,995
250,736
246,614
297,540
507,046
426,625
482,695
222,462
236,967
226,277
2,047,221
710,004
735,553
1,778,651
952,310
1,449,577
1,827,945
2,312,735
1,908,558
2,031,266
2,196,134
2,313,478
2,287,340
1,789,268
2,926,419
2,887,070
2,787,869
2,935,253
2,935,2532,787,8692,887,0702,926,4191,789,2682,287,3402,313,4782,196,1342,031,2661,908,5582,312,7351,827,9451,449,577952,3101,778,651735,553710,0042,047,221226,277236,967222,462482,695426,625507,046297,540246,614250,736891,995787,665751,798612,720621,712594,142590,234786,603820,9001,143,600583,278292,300247,500269,200389,252363,900436,400372,700485,262492,800567,300589,200663,578547,200566,200549,900550,184565,800619,900428,800453,866000
       Short-term Debt 
0
0
0
16,881
14,800
12,100
110,800
8,996
101,400
108,300
134,300
9,002
8,800
9,200
9,000
52,397
52,100
9,000
8,800
8,481
8,500
8,500
2,300
1,885
1,900
1,900
1,956
1,969
1,999
2,024
2,136
2,136
2,136
2,136
2,136
2,152
113,042
290,481
251,213
248,877
16,460
16,438
16,511
1,388,967
16,041
15,997
22,858
22,596
23,063
329,957
851,846
895,639
897,294
898,100
898,370
1,130,070
25,758
45,968
39,548
46,546
46,927
46,92746,54639,54845,96825,7581,130,070898,370898,100897,294895,639851,846329,95723,06322,59622,85815,99716,0411,388,96716,51116,43816,460248,877251,213290,481113,0422,1522,1362,1362,1362,1362,1362,0241,9991,9691,9561,9001,9001,8852,3008,5008,5008,4818,8009,00052,10052,3979,0009,2008,8009,002134,300108,300101,4008,996110,80012,10014,80016,881000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,109
31,394
30,786
2,154
20
20
2,392
2,151
2,536
2,148
2,148
2,148
1,375,116
2,163
2,163
2,163
2,174
2,173
308,878
830,787
874,373
874,372
874,373
874,372
1,105,583
1,923
1,924
1,923
1,913
1,913
1,9131,9131,9231,9241,9231,105,583874,372874,373874,372874,373830,787308,8782,1732,1742,1632,1632,1631,375,1162,1482,1482,1482,5362,1512,39220202,15430,78631,39432,1090000000000000000000000000000000
       Accounts payable 
0
0
0
48,020
23,600
59,600
45,200
50,085
63,700
75,500
39,800
84,401
72,600
64,100
82,100
104,167
41,300
83,600
88,600
113,510
61,900
87,400
69,800
58,666
67,200
47,200
51,557
69,574
35,429
56,397
45,909
71,958
42,126
34,322
36,452
82,901
36,261
71,545
37,048
93,962
93,881
112,051
116,951
112,088
150,910
201,496
296,174
345,320
273,291
298,545
222,795
263,611
204,418
195,456
381,904
605,928
444,834
764,233
793,693
954,142
480,274
480,274954,142793,693764,233444,834605,928381,904195,456204,418263,611222,795298,545273,291345,320296,174201,496150,910112,088116,951112,05193,88193,96237,04871,54536,26182,90136,45234,32242,12671,95845,90956,39735,42969,57451,55747,20067,20058,66669,80087,40061,900113,51088,60083,60041,300104,16782,10064,10072,60084,40139,80075,50063,70050,08545,20059,60023,60048,020000
       Other Current Liabilities 
0
0
0
388,965
389,700
546,900
407,900
103,180
384,800
381,800
372,600
162,733
142,300
158,900
134,700
489
1,100
800
1,200
2,747
3,900
6,800
6,700
17,176
199,800
12,100
10,857
20,490
13,016
13,366
16,847
18,047
13,152
18,107
9,082
2,723
1,247
1,876
992
275
4,521
4,598
14,017
1,135
1,634
5,256
5,463
4,849
30,010
27,901
45,175
23,917
809,139
984,353
1,013,877
551,342
1,318,676
1,814
-424
1,779,976
2,095,275
2,095,2751,779,976-4241,8141,318,676551,3421,013,877984,353809,13923,91745,17527,90130,0104,8495,4635,2561,6341,13514,0174,5984,5212759921,8761,2472,7239,08218,10713,15218,04716,84713,36613,01620,49010,85712,100199,80017,1766,7006,8003,9002,7471,2008001,100489134,700158,900142,300162,733372,600381,800384,800103,180407,900546,900389,700388,965000
   > Long-term Liabilities 
0
0
0
113,024
113,900
118,300
109,500
106,509
100,700
97,800
99,000
105,409
101,700
102,300
98,900
54,243
55,000
95,100
93,900
86,664
84,500
82,700
90,000
51,896
51,400
50,900
49,873
56,550
56,035
55,521
55,605
54,663
54,131
53,599
28,116
399,760
399,223
398,685
398,147
397,613
452,201
448,490
444,839
3,134,392
3,184,714
3,256,008
2,408,367
2,912,401
2,378,114
2,391,883
2,034,090
2,806,044
2,834,985
2,953,327
3,023,692
2,953,919
2,270,688
2,381,071
1,176,305
1,225,412
511,406
511,4061,225,4121,176,3052,381,0712,270,6882,953,9193,023,6922,953,3272,834,9852,806,0442,034,0902,391,8832,378,1142,912,4012,408,3673,256,0083,184,7143,134,392444,839448,490452,201397,613398,147398,685399,223399,76028,11653,59954,13154,66355,60555,52156,03556,55049,87350,90051,40051,89690,00082,70084,50086,66493,90095,10055,00054,24398,900102,300101,700105,40999,00097,800100,700106,509109,500118,300113,900113,024000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,949
24,949
24,949
0
0
0
0
0
0
0
0
0
2,691,400
2,715,580
2,789,858
1,954,280
2,464,932
1,915,908
1,934,498
1,953,519
2,729,601
2,759,251
2,881,056
2,956,888
2,891,077
0
2,305,328
1,109,761
0
0
001,109,7612,305,32802,891,0772,956,8882,881,0562,759,2512,729,6011,953,5191,934,4981,915,9082,464,9321,954,2802,789,8582,715,5802,691,40000000000024,94924,94924,9490000000000000000000000000000000
> Total Stockholder Equity
0
0
0
704,214
899,600
822,300
695,300
810,435
726,500
1,276,200
1,196,400
1,207,600
1,195,000
1,019,700
1,052,300
999,676
961,500
966,100
996,600
976,290
978,700
925,000
881,500
1,252,094
1,268,900
1,348,800
1,302,663
1,342,479
1,212,433
1,804,481
1,914,596
2,017,237
2,039,770
2,122,605
2,637,388
2,506,297
2,333,053
2,249,831
2,278,541
2,180,628
2,087,152
1,986,577
1,892,102
1,865,455
5,110,553
5,251,149
5,264,117
4,894,353
5,920,743
5,788,550
5,770,699
7,374,667
7,125,298
6,879,095
6,957,830
7,149,987
9,120,901
9,685,751
9,335,863
10,339,932
10,174,272
10,174,27210,339,9329,335,8639,685,7519,120,9017,149,9876,957,8306,879,0957,125,2987,374,6675,770,6995,788,5505,920,7434,894,3535,264,1175,251,1495,110,5531,865,4551,892,1021,986,5772,087,1522,180,6282,278,5412,249,8312,333,0532,506,2972,637,3882,122,6052,039,7702,017,2371,914,5961,804,4811,212,4331,342,4791,302,6631,348,8001,268,9001,252,094881,500925,000978,700976,290996,600966,100961,500999,6761,052,3001,019,7001,195,0001,207,6001,196,4001,276,200726,500810,435695,300822,300899,600704,214000
   Common Stock
0
0
0
79,517
119,100
119,100
119,100
129,620
129,600
258,800
258,800
260,944
260,900
260,900
260,900
260,944
260,900
260,900
260,900
260,944
260,900
261,100
261,100
276,712
277,300
278,100
278,344
280,197
280,657
309,282
309,341
313,539
314,236
314,693
319,814
322,451
322,451
323,106
323,106
323,106
323,106
323,206
323,891
323,891
583,003
584,501
584,501
584,501
637,368
638,172
640,651
704,684
704,729
704,793
706,943
707,354
778,730
779,286
779,286
780,978
780,978
780,978780,978779,286779,286778,730707,354706,943704,793704,729704,684640,651638,172637,368584,501584,501584,501583,003323,891323,891323,206323,106323,106323,106323,106322,451322,451319,814314,693314,236313,539309,341309,282280,657280,197278,344278,100277,300276,712261,100261,100260,900260,944260,900260,900260,900260,944260,900260,900260,900260,944258,800258,800129,600129,620119,100119,100119,10079,517000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,257
65,170
61,593
82,187
97,880
93,063
120,371
143,521
117,744
141,038
131,797
230,489
173,808
173,808230,489131,797141,038117,744143,521120,37193,06397,88082,18761,59365,17060,257000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
34,013
13,200
-8,200
28,400
29,407
44,600
57,600
28,500
23,623
40,400
33,500
46,300
683,032
38,100
48,000
58,100
63,325
64,600
43,800
18,600
3,061
-41,300
-28,900
-27,813
-4,276
-8,389
-22,769
-9,800
-28,200
-7,550
29,079
13,067
26,963
36,164
56,134
53,076
60,400
63,649
67,864
60,157
81,557
82,681
90,506
92,139
63,493
-946
-1,176
-1,176
-1,112
-871
-1,463
-1,463
-1,463
-1,298
-1,537
-1,537
-1,537
-1,291
-1,291-1,537-1,537-1,537-1,298-1,463-1,463-1,463-871-1,112-1,176-1,176-94663,49392,13990,50682,68181,55760,15767,86463,64960,40053,07656,13436,16426,96313,06729,079-7,550-28,200-9,800-22,769-8,389-4,276-27,813-28,900-41,3003,06118,60043,80064,60063,32558,10048,00038,100683,03246,30033,50040,40023,62328,50057,60044,60029,40728,400-8,20013,20034,013000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.